Leading MedTech Executive, Peter Traianou, Joins NEMIC Board of Directors
Providence, Rhode Island | July 2025 — Leading MedTech executive Peter Traianou has officially joined the Board of Directors at the New England Medical Innovation Center (NEMIC), reinforcing the organization’s mission to accelerate medical device innovation and commercialization in the region.
Traianou brings decades of experience in global MedTech and surgical robotics. His previous and ongoing roles include board memberships at VeinTech, CytoVeris, and Matrix Plastic Products, alongside advisory roles with companies such as ArthroLase, Palliare, and IMRA. His expertise in navigating products through clinical, regulatory, and market-entry stages positions him as a valuable resource for NEMIC’s growth strategy.
NEMIC’s Executive Director, Maey Petrie‑Healey, said Traianou’s appointment underscores the center’s momentum following its recent expansion of the board and launch of expert advisory groups. His leadership is expected to contribute significantly to strategic planning, investor engagement, and global partnership development.
As Rhode Island continues to emerge as a growing hub for medical innovation, Traianou’s involvement positions NEMIC to play an even stronger role in ecosystem growth—supporting founders, engaging investors, and forging strategic partnerships that can scale MedTech innovations globally. His diverse leadership across both entrepreneurial and commercialization-focused organizations reflects a keen ability to connect innovation teams with markets and allies worldwide. As NEMIC continues its trajectory as a catalyst for health care innovation—particularly in Rhode Island’s rising MedTech scene—Traianou’s appointment sends a clear signal: strategic and commercial leadership is a cornerstone of future success.
What This Means for NEMIC
Strategic Expansion: Traianou joins at a time when NEMIC is broadening its international cohorts and launching new support programs, including its EMPOWER initiative focused on founders from underrepresented backgrounds.
Capitalising on Global Networks: With connections spanning the U.S., Australia, Europe, and beyond, he will help open pathways for cohort companies to access international markets and investment networks.
Commercialization and Scaling: Traianou’s track record guiding startups through commercialization—especially in the early stages of product rollout and clinical adoption—aligns with NEMIC’s mission to bring practical health technology solutions to market.
Please join us in welcoming Peter to our Board!
